Package 67457-992-02

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67457-992-02
Digits Only 6745799202
Product NDC 67457-992
Product ID 67457-992_aa56cac5-0a95-4536-832d-5f24e921118f
Description

1 SYRINGE, GLASS in 1 CARTON (67457-992-02) / 2 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Marketed Since 2022-12-02
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Naloxone Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "aa56cac5-0a95-4536-832d-5f24e921118f", "openfda": {"upc": ["0367457992020"], "unii": ["F850569PQR"], "rxcui": ["1191250"], "spl_set_id": ["7faaedb3-227b-408d-b772-6b326638b00e"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (67457-992-02)  / 2 mL in 1 SYRINGE, GLASS", "package_ndc": "67457-992-02", "marketing_start_date": "20221202"}], "brand_name": "Naloxone Hydrochloride", "product_id": "67457-992_aa56cac5-0a95-4536-832d-5f24e921118f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "67457-992", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA213843", "marketing_category": "ANDA", "marketing_start_date": "20221202", "listing_expiration_date": "20261231"}